• News
  • SAN DIEGO
  • BioTech

OxyContin maker to offer abuse-resistant Zohydro

The maker of OxyContin says it has completed testing of an abuse-resistant version of the painkiller hydrocodone, a surprise development that could derail sales of the recently launched Zohydro, which has been heavily criticized for lacking such safeguards.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Zogenix Inc.

Company Website

12400 High Bluff Dr. Ste., 650
San Diego, CA 92130

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ZGNX
1.18
  0.02  
+ 1.72%
1,229,569,000
5.19
1.14

Zogenix Inc. Executive(s):

Roger Hawley

  • Chief Executive Officer

Stephen Farr

  • President

Ann Rhoads

  • Chief Financial Officer
Subscribe Today!